Intellectual property law in China has steadily improved in recent years, and there has been a considerable increase in the number of patents filed in China. This article is a Q&A with Finnegan partner Ningling Wang: Ms. Wang, whose practice involves several areas, including pharmaceuticals, chemicals, medical devices, and nanotechnology, discusses the evolving climate for intellectual property and patents in China. Ms. Wang has extensive experience working with multinational big-pharma companies and domestic organizations in China. During the interview, Ms. Wang answers questions about how much the patent climate has improved in China in recent years (a lot); whether patent activity has increased (domestic China patent applications filed by foreign companies has greatly increased); and whether the Chinese government is good about encouraging companies to come in and conduct innovative research (yes). Ms. Wang concludes, however, that the growing system in China and the legal framework for venture capital arrangements still involve uncertainties.
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Award/Ranking
World Trademark Review Recognizes Three Finnegan Partners on its 2026 Global Leaders List
June 24, 2026
Press Release
London-Based Life Sciences Litigator Jin Ooi Bolsters Finnegan’s Global IP Litigation Capabilities
June 8, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.